Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-05-10

FDA Approved: AMELUZ — Original Application (Biofrontera Inc.)

View source ↗

Summary

The FDA approved AMELUZ (aminolevulinic acid hydrochloride) from Biofrontera for the topical treatment of actinic keratosis of the face and scalp in adults when…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMELUZ (AMINOLEVULINIC ACID HYDROCHLORIDE)

Snippet

ORIG AP for AMELUZ (AMINOLEVULINIC ACID HYDROCHLORIDE)